Alphs LD - Search Results

1

Neuronal cholecystokinin and schizophrenia: pathogenic and therapeutic studies.

Tamminga CA, Littman RL, Alphs LD, Chase TN, Thaker GK, Wagman AM. Tamminga CA, et al. Among authors: alphs ld. Psychopharmacology (Berl). 1986;88(3):387-91. doi: 10.1007/BF00180843. Psychopharmacology (Berl). 1986. PMID: 3083460

2

Cholecystokinin: a neuropeptide in the treatment of schizophrenia.

Tamminga CA, Littman RL, Alphs LD. Tamminga CA, et al. Among authors: alphs ld. Psychopharmacol Bull. 1986;22(1):129-32. Psychopharmacol Bull. 1986. PMID: 3726058 Clinical Trial. No abstract available.

3

Dopamine agonist treatment of schizophrenia with N-propylnorapomorphine.

Tamminga CA, Gotts MD, Thaker GK, Alphs LD, Foster NL. Tamminga CA, et al. Among authors: alphs ld. Arch Gen Psychiatry. 1986 Apr;43(4):398-402. doi: 10.1001/archpsyc.1986.01800040108015. Arch Gen Psychiatry. 1986. PMID: 2869745 Clinical Trial.

4

Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome.

Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT. Tamminga CA, et al. Among authors: alphs ld. Arch Gen Psychiatry. 1992 Jul;49(7):522-30. doi: 10.1001/archpsyc.1992.01820070016003. Arch Gen Psychiatry. 1992. PMID: 1627043

5

Dopamine neuronal tracts in schizophrenia: their pharmacology and in vivo glucose metabolism.

Tamminga CA, Burrows GH, Chase TN, Alphs LD, Thaker GK. Tamminga CA, et al. Among authors: alphs ld. Ann N Y Acad Sci. 1988;537:443-50. doi: 10.1111/j.1749-6632.1988.tb42126.x. Ann N Y Acad Sci. 1988. PMID: 2904785 Review. No abstract available.

6

Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment.

Thaker GK, Tamminga CA, Alphs LD, Lafferman J, Ferraro TN, Hare TA. Thaker GK, et al. Among authors: alphs ld. Arch Gen Psychiatry. 1987 Jun;44(6):522-9. doi: 10.1001/archpsyc.1987.01800180032006. Arch Gen Psychiatry. 1987. PMID: 3034188 Clinical Trial.

7

Impaired Wisconsin Card Sort performance in schizophrenia may reflect motivational deficits.

Summerfelt AT, Alphs LD, Funderburk FR, Strauss ME, Wagman AM. Summerfelt AT, et al. Among authors: alphs ld. Arch Gen Psychiatry. 1991 Mar;48(3):282-3. doi: 10.1001/archpsyc.1991.01810270094019. Arch Gen Psychiatry. 1991. PMID: 1996924 No abstract available.

8

Reduction of perseverative errors in patients with schizophrenia using monetary feedback.

Summerfelt AT, Alphs LD, Wagman AM, Funderburk FR, Hierholzer RM, Strauss ME. Summerfelt AT, et al. Among authors: alphs ld. J Abnorm Psychol. 1991 Nov;100(4):613-6. doi: 10.1037//0021-843x.100.4.613. J Abnorm Psychol. 1991. PMID: 1757677

9

Labile hypertension after antipsychotic drug withdrawal: a case report.

Thaker GK, Alphs L, Tamminga CA. Thaker GK, et al. Biol Psychiatry. 1985 Nov;20(11):1244-6. doi: 10.1016/0006-3223(85)90184-2. Biol Psychiatry. 1985. PMID: 4052522 No abstract available.

10

The negative symptom assessment: a new instrument to assess negative symptoms of schizophrenia.

Alphs LD, Summerfelt A, Lann H, Muller RJ. Alphs LD, et al. Psychopharmacol Bull. 1989;25(2):159-63. Psychopharmacol Bull. 1989. PMID: 2602512 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters